28 September 2023
Healthcare is under pressure, but technology can help solve its challenges
LUMO Fund II Seed Capital announces an undisclosed investment in neurotechnology startup Maaind. The startup proposition is based on neuroadaptive machine learning and AI-enabled platform integrations for everyday products and services.
Maaind is active in the United Kingdom, Germany and the Netherlands and has partnerships with several well-established consumer-facing companies. The LUMO Labs funding will be used to solidify these partnerships, to attract new partners and to continue research and development of neurotechnology and the AI algorithms behind the Maaind platform.
Maaind combines and connects third-party smart systems and wearables. Maaind’s algorithms measure the emotional and stress state from speech analysis, wearables and the environment, then uses the data to offer suggestions and recommendations for users tailored to their psychological or physical state.
For example, the platform can improve the mood or energy level of drivers and passengers in cars, providing music recommendations or breathing exercises. This is the core concept behind “neuroadaptive” algorithms and one of the key innovations in Maaind’s platform.
“With this investment, we don’t invest in just one application of neuroadaptive AI. We invest in the fundamental infrastructure to make the ongoing innovation and development of AI accessible for all, specifically AI to improve health and well-being.”
In line with LUMO Labs’ advocacy for self-determination and traceable ownership of data and transparency and traceability of technologies, the Maaind platform is designed to uphold the highest possible privacy standards.
“With our proven, effective tech, we can help millions of people feel better,” said Martin Dinov, Maaind co-founder and CEO. “We also make it easier for other businesses to make their groundbreaking applications and technology available, safer and faster. By integrating with the Maaind platform, these businesses can focus on perfecting their proprietary sensor technology or AI-enabled well-being applications without the additional burden of developing the basic infrastructure for capture, consolidation and computing to make this happen.”
“We appreciate the rigorous approach and dedication we see in Martin and Dzera,” said Sven Bakkes, LUMO Labs founding partner. “This has already resulted in tangible milestones for Maaind. These not only prove the effectiveness of technology but also the relevance of the technology for a wide range of consumer-facing brands and businesses.”
“We are thrilled to have the LUMO team on this journey with us. We couldn’t think of better partners at this stage of our journey than Andy and Sven,” said Dzera Kaytati, Maaind co-founder and COO. “They truly understand the value and the potential of our technology and are driven by the same passion for bringing positive impact to the world as we are.”
Maaind was founded in London in 2019 by Dr. Martin Dinov and Dzera Kaytati and subsequently raised pre-seed funding from Entrepreneur First and vision-aligned angel investors from the UK and the U.S.
The founders and the rest of the growing Maaind team will work from their new headquarters at the High Tech Campus in Eindhoven and their existing offices in London.